Evaluation of population‐level pharmacogenetic actionability in Alabama
Abstract The evolution of evidence and availability of Clinical Pharmacogenetic Implementation Consortium (CPIC) guidelines have enabled assessment of pharmacogenetic (PGx) actionability and clinical implementation. However, population‐level actionability is not well‐characterized. We leveraged the...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Wiley
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/d2f206528b0f46e5aa0f3e0e2001aa3f |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|